A Phase I Trial of Irinotecan, Radiation Therapy and Escalating Doses of Docetaxel With Cisplatin in Locally Advanced Esophageal Cancer.
Phase of Trial: Phase I
Latest Information Update: 21 Mar 2013
At a glance
- Drugs Docetaxel (Primary) ; Cisplatin; Irinotecan
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions
- 01 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Dec 2006 New trial record.